Login
From:
Myasthenia Gravis News
(Uncensored)
subscribe
RMAT status awarded to experimental cell therapy KYV-101 for treating MG
https://myastheniagravisnews.com/news/rmat-status-experimental-cell-therapy-kyv-101-mg/
links
backlinks
Tagged with:
car t-cell therapy
kyv-101
An open-label, multicenter Phase 2 clinical trial will test KYV-101 in people with refractory MG and positive for self-reactive antibodies.
Roast topics
Find topics
Find it!
